In light of the letter dated Jan. 25 from the Centers for Medicare and
Medicaid Services (CMS) to Theranos, Inc., Walgreens said today that it
has informed Theranos that it must immediately cease sending any
clinical laboratory tests provided through Theranos Wellness Centers at
Walgreens to the Theranos lab in Newark, Calif., for analysis. In
addition, Walgreens is suspending Theranos laboratory services at its
Palo Alto, Calif., store, effective immediately.
Walgreens informed Theranos that tests collected at 40 Theranos Wellness
Centers located at stores in Arizona must be sent only to Theranos'
certified lab in the Phoenix area or to an accredited third-party lab
for analysis. No patient samples will be sent to the Newark lab until
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in